Our data indicate that an increase in serum MMP-9 may precede the development of obesity and disturbances of glucose tolerance and that the offspring of type 2 diabetic patients are at elevated risk for CVD. This evidence concerns the gene MMP9 and obesity due to melanocortin 4 receptor deficiency.